Glucosamine-bound near-infrared fluorescent probes with lysosomal specificity for breast tumor imaging

Neoplasia

Volumn 10, Issue 4, 2008, Pages 389-398

  Li, Cong ^a   Greenwood, Tiffany R ^a   Glunde, Kristine ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD63 ANTIGEN; GLUCOSAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMAGING; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LYSOSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

EID: 41649088405     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07856     Document Type: Article

References (40)

1. de Duve C (1983). Lysosomes revisited. Eur J Biochem 137, 391-397.
2. Rawlings ND, Morton FR, and Barrett AJ (2006). MEROPS: the peptidase database. Nucleic Acids Res 34, D270-D272.
3. Gocheva V and Joyce JA (2007). Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6, 60-64.
4. Mignatti P and Rifkin DB (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73, 161-195.
5. Kroemer G and Jaattela M (2005). Lysosomes and autophagy in cell death control. Nat Rev Cancer 5, 886-897.
6. Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, and Gillies RJ (2006). Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res 66, 5216-5223.
7. Glunde K, Guggino SE, Solaiyappan M, Pathak AP, Ichikawa Y, and Bhujwalla ZM (2003). Extracellular acidification alters lysosomal trafficking in human breast cancer cells. Neoplasia 5, 533-545.
8. Mohamed MM and Sloane BF (2006). Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6, 764-775.
9. Daugaard M, Kirkegaard-Sorensen T, Ostenfeld MS, Aaboe M, Hoyer-Hansen M, Orntoft TF, Rohde M, and Jaattela M (2007). Lens epithelium-derived growth factor is an Hsp70-2 regulated guardian of lysosomal stability in human cancer. Cancer Res 67, 2559-2567.
10. Groth-Pedersen L, Ostenfeld MS, Hoyer-Hansen M, Nylandsted J, and Jäättelä M (2007). Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res 67, 2217-2225.
11. Kusuzaki K, Murata H, Matsubara T, Satonaka H, Wakabayashi T, Matsumine A, and Uchida A (2007). Review. Acridine orange could be an innovative anticancer agent under photon energy. In Vivo 21, 205-214.
12. Mijatovic T, Mathieu V, Gaussin JF, De Neve N, Ribaucour F, Van Quaquebeke E, Dumont P, Darro F, and Kiss R (2006). Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia 8, 402-412.
13. Ichinose S, Usuda J, Hirata T, Inoue T, Ohtani K, Maehara S, Kubota M, Imai K, Tsunoda Y, Kuroiwa Y, et al. (2006). Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na). Int J Oncol 29, 349-355.
14. Shah N, Cerussi A, Eker C, Espinoza J, Butler J, Fishkin J, Hornung R, and Tromberg B (2001). Noninvasive functional optical spectroscopy of human breast tissue. Proc Natl Acad Sci USA 98, 4420-4425.
15. Koyama Y, Hama Y, Urano Y, Nguyen DM, Choyke PL, and Kobayashi H (2007). Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res 13, 2936-2945.
16. Pogue BW, Poplack SP, McBride TO, Wells WA, Osterman KS, Osterberg UL, and Paulsen KD (2001). Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. Radiology 218, 261-266.
17. Ntziachristos V, Yodh AG, Schnall MD, and Chance B (2002). MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 4, 347-354.
18. Hama Y, Koyama Y, Choyke PL, and Kobayashi H (2007). Two-color in vivo dynamic contrast-enhanced pharmacokinetic imaging. J Biomed Opt 12, 034016.
19. Bremer C, Tung CH, Bogdanov A Jr, and Weissleder R (2002). Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology 222, 814-818.
20. Koyama Y, Barrett T, Hama Y, Ravizzini G, Choyke PL, and Kobayashi H (2007). In vivo molecular imaging to diagnose and sub-type tumors via receptor-targeted optically-labeled monoclonal antibodies. Neoplasia 9, 1021-1029.
21. Zhang G-J, Chen TB, Bednar B, Connolly BM, Hargreaves R, Sur C, and Williams DL (2007). Optical imaging of tumor cells in hollow fibers; evaluation of anti-tumor activities of anti-cancer drugs and target validation. Neoplasia 9, 652-661.
22. Pham W, Xie J, and Gore JC (2007). Tracking the migration of dendritic cells by in vivo optical imaging. Neoplasia 9, 1130-1137.
23. Achilefu S (2004). Lighting up tumors with receptor-specific optical molecular probes. Technol Cancer Res Treat 3, 393-409.
24. O'Neil RG, Wu L, and Mullani N (2005). Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Mol Imaging Biol 7, 388-392.
25. Zhang M, Zhang Z, Blessington D, Li H, Busch TM, Madrak V, Miles J, Chance B, Glickson JD, and Zheng G (2003). Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. Bioconjug Chem 14, 709-714.
26. Ye Y, Bloch S, Kao J, and Achilefu S (2005). Multivalent carbocyanine molecular probes: synthesis and applications. Bioconjug Chem 16, 51-61.
27. Gambhir SS (2002). Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2, 683-693.
28. Glunde K, Guggino SE, Ichikawa Y, and Bhujwalla ZM (2003). A novel method of imaging lysosomes in living human mammary epithelial cells. Mol Imaging 2, 24-36.
29. Glunde K, Foss CA, Takagi T, Wildes F, and Bhujwalla ZM (2005). Synthesis of 6′-O-lissamine-rhodamine B-glucosamine as a novel probe for fluorescence imaging of lysosomes in breast tumors. Bioconjug Chem 16, 843-851.
30. Li C, Greenwood TR, Bhujwalla ZM, and Glunde K (2006). Synthesis and characterization of glucosamine-bound near-infrared probes for optical imaging. Org Lett 8, 3623-3626.
31. Zhang Z, Liang K, Bloch S, Berezin M, and Achilefu S (2005). Monomolecular multimodal fluorescence-radioisotope imaging agents. Bioconjug Chem 16, 1232-1239.
32. Rejman J, Bragonzi A, and Conese M (2005). Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol Ther 12, 468-474.
33. Metzelaar MJ, Wijngaard PL, Peters PJ, Sixma JJ, Nieuwenhuis HK, and Clevers HC (1991). CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 266, 3239-3245.
34. 18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 22, 360-371.
35. Cheng Z, Levi J, Xiong Z, Gheysens O, Keren S, Chen X, and Gambhir SS (2006). Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem 17, 662-669.
36. Loaiza A, Porras OH, and Barros LF (2003). Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J Neurosci 23, 7337-7342.
37. Brockhausen I (2006). Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 7, 599-604.
38. Couldrey C and Green JE (2000). Metastases: the glycan connection. Breast Cancer Res 2, 321-323.
39. 3+-(DO3A-like) complex functionalized with aza-15-crown-5 showing prolonged residence lifetime in vivo. Bioconjug Chem 17, 571-574.
40. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, and Speck U (1992). Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183, 59-64.